Tue, Dec 23, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Only few opportunities left in mortgage market - Ayaltis

Monday, December 03, 2012

amb
Ernesto Prado
From Precy Dumlao, Opalesque Asia:

A good number of high risk premium asset class managers benefited when Federal Reserve Chairman Ben Bernanke started the next round of QE3. QE3 lifted the equity markets to more than 15% so far this year and helped deliver "QEsubsidized" performance, said Ernesto Prado Ayaltis, a boutique fund of funds, during the recent Opalesque 2012 Zurich Roundtable.

The Zurich Roundtable took in the offices of our series sponsor Eurex; it was also sponsored by IDS Funds Services and Taussig Capital.

Without the latest QE, fund managers would not have seen such gains neither for corporate bonds nor for equities, Prado explained, "for that reason, during the next couple of years, we prefer to invest into the lower risk premium assets while still trying to anchor ourselves as close as we can to the printing power of Bernankes and other central bankers printing presses - the same mortgage asset classes we targeted since December of 2008 and which have strongly helped our returns be fantastic."

In September, Bernanke announced a third round of quantitative easing, or QE3. It included a plan to purchase $40bn of mortgage-backed securities per month. ......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its